Back to top
more

Blackrock Health Sciences Opportunities Portfolio Class R Shares: (MF: BHSRX)

(NASDAQ Mutual Funds) As of Feb 27, 2026 01:00 PM ET

$62.63 USD

0.00 (NA)

Zacks MF Rank

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

3-Hold of 5     3    

View All Zacks Mutual Fund Rank #1's

Latest Performance as of Jan 31, 2026

Total Return %* Percentile Rank Objective
YTD 0.06 52
3 months 6.84 61
6 months 19.20 73
1 Year 8.10 63
3 Year 7.62 48
5 Year 5.20 47
10 Year 10.42 36

* Annual for three years and beyond.

Zacks Premium Research for BHSRX

Zacks MF Rank

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

Hold 3
MF Report

Mutual Funds Research & Tools

Search Similar Mutual Funds

Research similar Mutual Funds with higher ranks and performance ratings.

Mutual Funds Comparison View (minimum of 2)

Mutual Funds Screener

Narrow down the universe of 18,000+ funds we rank with our robust, yet easy-to-use mutual fund screeners. Select from up to 50 different data points to find the mutual funds that best Screen meet your unique criteria.

Portfolio Statistics

% Unrealized Gain 46.91
% Yield NA
% SEC Yield NA
Net Assets (Mil $) 1/31/2026 221.76
% Turnover 1/31/2026 43.00

Risk

3 Year 5 Year 10 Year
Beta 0.63 0.61 0.68
Alpha -5.94 -4.47 -0.52
R Squared 0.32 0.46 0.55
Std. Dev. 12.77 13.60 13.89
Sharpe 0.28 0.21 3.00

Sector / Country Weightings

As of 1/31/2026 % of Portfolio
Health 62.45
Services 10.33
Finance 7.07
Technology 6.40
Other 5.80
Retail Trade 3.77
Industrial Cyclical 3.72
Non-Durable 0.46

Portfolio Holdings

Top Equity Holdings
(As of 11/30/2025)
% of Portfolio Value (Mil$)
ELI LILLY & CO 10.89 739.08
JOHNSON & JOHNSON 8.37 568.32
ABBOTT LABORATORIES 5.03 341.31
ABBVIE INC 3.97 269.32
THERMO FISHER SCIENTIFIC 3.69 250.74
UNITEDHEALTH GROUP INC 3.58 242.72
AMGEN INC 3.41 231.57
MEDTRONIC PLC 3.37 228.50
GILEAD SCIENCES INC 2.94 199.49

Stock Holding % of Net Assets

As Of 11/30/2025
Total Issues 138
Avg. P/E 27.04
Avg. P/Book 5.77
Avg. EPS Growth 12.49
Avg. Market Value (Mil $) 269,740

Composition

% of Portfolio
Stocks 98.86
Foreign Stocks 9.91
Cash 1.06
Bonds 0.00
Foreign Bonds 0.00
Preferred 0.60
Convertible 0.00
Other -0.52
Foreign Hedged 0.00

Style Analysis

% of Portfolio
Large Growth NA
Large Value NA
Small Growth NA
Small Value NA
Foreign Stock NA
Emerging Market NA
Precious Metal NA
Intermediate Bond NA
Foreign Bond NA
High Yield Bond NA